Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Musculoskeletal Adverse Events Following BCMA CAR T-Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates.
Journal: Transplantation and cellular therapy
Published: November 05, 2025
A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC.
Journal: Cancers
Published: April 13, 2025
β-Arrestin 2 as a Prognostic Indicator and Immunomodulatory Factor in Multiple Myeloma.
Journal: Cells
Published: February 25, 2025
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.
Journal: Therapeutic advances in medical oncology
Published: March 23, 2023
Role of COPD in a case of fatal Aspergillus niger tracheobronchitis.
Journal: BMJ case reports
Published: March 22, 2023
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature.
Journal: Therapeutic advances in medical oncology
Published: March 20, 2023
Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature.
Journal: Therapeutic advances in medical oncology
Published: May 17, 2022
Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.
Journal: Cancers
Published: September 24, 2021
In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma.
Journal: The oncologist
Published: July 31, 2021
Last Updated: 09/26/2026